| Particulars |
| Company Name |
Natco Pharma Ltd |
| Face Value |
2 |
| BSE Code |
524816 |
| Year End |
202603 |
| Full Year |
| Equity (Rs in Cr.) |
35.82 |
| B.V. Rs |
477.50 |
| Sales Rs in Cr. |
3,594.60 |
| NP Rs in Cr. |
1,281.50 |
| NP Var% |
-28.00 |
| Div% |
250.00 |
| CPS Rs |
82.10 |
| EPS Rs |
71.50 |
| Traded Value(Rs in Lakhs) |
340.74 |
| 52 Week High |
1,226.00 |
| 52 Week Low |
789.00 |
| Price BSE |
826.00 |
| Price NSE |
826.00 |
| Market Capital(Rs in Cr.) |
14,796.27 |
| P/C Ratio |
10.10 |
| P/E Ratio |
11.50 |
| Price Vs.BV |
1.73 |
| Latest Quarter |
| Year End |
202606 |
| Sales Rs in Cr. |
596.60 |
| NP Rs in Cr. |
74.60 |
| NP Var % |
-84.00 |
| Trailing Twelve Months |
| Year End |
202606 |
| Sales |
4,119.60 |
| OPM |
54.49 |
| NP |
1,838.50 |
| NP Var% |
-46.85 |
| EPS |
49.80 |
| PE |
16.59 |
|